Leerink Swann today maintained a Market Perform rating on AVEO Pharmaceuticals (NASDAQ: AVEO). This morning the FDA expressed concern about ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE